These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12264716)

  • 1. Controlled release of contraceptive steroids from biodegradable poly (ortho esters).
    Heller J; Penhale DW; Fritzinger BK; Rose JE; Helwing RF
    Contracept Deliv Syst; 1983 Jan; 4(1):43-53. PubMed ID: 12264716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(ortho ester) biodegradable polymer systems.
    Heller J; Himmelstein KJ
    Methods Enzymol; 1985; 112():422-36. PubMed ID: 3930918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyacetal and poly(ortho ester)-poly(ethylene glycol) graft copolymer thermogels: preparation, hydrolysis and FITC-BSA release studies.
    Schacht E; Toncheva V; Vandertaelen K; Heller J
    J Control Release; 2006 Nov; 116(2):219-25. PubMed ID: 16962198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Where next with long-acting steroids?
    Potts DM; Siemens AJ
    IPPF Med Bull; 1984 Jun; 18(3):2-3. PubMed ID: 12266285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three triphasic oral contraceptives now available in U.S.
    Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ortho esters)--from concept to reality.
    Heller J; Barr J
    Biomacromolecules; 2004; 5(5):1625-32. PubMed ID: 15360265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capronor.
    Research Triangle Institute
    Hypotenuse; 1985; ():2-5. PubMed ID: 12340513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Choosing the right synthetic progestogen].
    Rozenbaum H
    Contracept Fertil Sex (Paris); 1983 Nov; 11(11):1233-42. PubMed ID: 12312705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro drug release from self-catalyzed poly(ortho ester): case study of 5-fluorouracil.
    Sintzel MB; Heller J; Ng SY; Tabatabay C; Schwach-Abdellaoui K; Gurny R
    J Control Release; 1998 Nov; 55(2-3):213-8. PubMed ID: 9795063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum cortisol in women users of subdermal levonorgestrel implants.
    Bayad MA; Ibrahim II; Fayad MM; Hassanein AA; Hafez ES; Abdalla MI
    Contracept Deliv Syst; 1983 Apr; 4(2):133-5. PubMed ID: 12338633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sister chromatid exchanges in women taking oral contraceptive tablet norethindroni compositae for a long term].
    Qi SY; Fan YS
    Shengzhi Yu Biyun; 1982; 2(4):42-3. PubMed ID: 12281507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future contraceptive methods.
    Contracept Rep; 1994 Sep; 5(4):4-12. PubMed ID: 12345631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preclinical research and development of norethisterone].
    Mcguire JL; Hahn DW; Philipps A
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):437-44. PubMed ID: 12280212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
    Rubio-lotvin B; Ruiz-moreno JA; Gonzalez-ansorena R
    Adv Contracept Deliv Syst; 1992; 8(1-2):75-88. PubMed ID: 12285566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corpus luteum function in subdermal levonorgestrel implant users.
    Ibrahim II; Abdalla MI; Osman MI; Hassanein AA; Toppozada MH; Abdelaal AE; Hafez ES
    Contracept Deliv Syst; 1983 Sep; 4(4):317-21. PubMed ID: 12265808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of some coagulation tests in women using low dosage oral contraception].
    Gramolini R; Perrone G; Calzolari E; Mancone M; Masci A; Materazzi P; Serafini P; Zichella L
    Patol Clin Ostet Ginecol; 1987; 15(5):307-12. PubMed ID: 12282061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier.
    Lee JS; Chae GS; Kim MS; Cho SH; Lee HB; Khang G
    Biomed Mater Eng; 2004; 14(2):185-92. PubMed ID: 15156109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subdermal levonorgestrel implants: serum androgens.
    Osman MI; Abdalla MI; Toppozada MH; Bayad MA; Ibrahim II; Hafez EZ
    Contracept Deliv Syst; 1983 Apr; 4(2):127-31. PubMed ID: 12338632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.